Table 3 Comparison of the study’ variables at the baseline (phase I) and the end of the second phase in the lavender and control groups
Parameters | Lavender Group (Mean ± SD) | Control Group (Mean ± SD) | ||||||
|---|---|---|---|---|---|---|---|---|
Phase I | Phase II | Change | P- value | Baseline | Phase 2 | Change | P-value | |
SBP | 140.56 ± 16.53 | 133.16 ± 12.20 | - 7.4 ± 12.34 | 0.021 | 142.32 ± 12.36 | 137.09 ± 10.04 | - 5.23 ± 11.24 | 0.143 |
DBP | 81.63 ± 11.24 | 80.43 ± 6.87 | - 1.2 ± 10.25 | 0.062* | 80.45 ± 10.23 | 79.69 ± 9.98 | - 0.76 ± 10.54 | 0.239 |
HR | 76.61 ± 10.21 | 69.26 ± 7.76 | - 7.35 ± 9.21 | 0.041 | 76.81 ± 11.23 | 71.68 ± 5.67 | - 5.13 ± 2.98 | 0.042$ |
RR | 17.82 ± 1.30 | 16.48 ± 0.78 | - 1.34 ± 0.12 | 0.041 | 17.80 ± 1.34 | 16.82 ± 6.98 | - 0.98 ± 2.14 | 0.214 |
Spo2 | 96.65% ± 1.78 | 97.98% ± 1.96 | + 1.33% ± 0.25 | 0.032 | 96.22% ± 2.89 | 96.78% ± 0.87 | + 0.56% ± 0.29 | 0.367 |
MDAS | 7.43 ± 0.121 | 5.22 ± 0.54 | - 2.21 ± 0.13 | 0.012 | 7.73 ± 0.15 | 7.30 ± 0.98 | - 0.43 ± 0.21 | 0.340 |
STAI | 75.54 ± 10.65 | 70.84 ± 9.91 | - 4.7 ± 8.60 | 0.011 | 76.58 ± 11.12 | 76.02 ± 0.87 | - 0. 56 ± 0.43 | 0.653 |
Pain score | 89.78 ± 1.23 | 80.96 ± 0.87 | - 8.82 ± 3.34 | 0.023 | 93.21 ± 2.23 | 90.84 ± 4.76 | - 2.37 ± 0.67 | 0.087 |